Cosmo Bio Company,Limited's Equity Buyback announced on February 12, 2021, has closed with 160,000 shares, representing 2.71% for ¥194.04 million.

COSMO BIO COMPANY,LIMITED is a Japan-based company mainly engaged in purchase and wholesale of research reagents, equipment, consignment services and clinical test drugs related to life science. Research reagents business imports majority research reagents from United States and Europe, which are prioritized in life science related research. In the equipment business, the Company handles equipment specialized in life science research, purchases goods from a wide range of domestic and overseas, and mainly sells it to the domestic market. The equipment includes ultrasonic cell disruption equipment, bioimaging related equipment and research consumables. The Company provides clinical test drugs mainly used at hospitals and testing centers.